Literature DB >> 16910802

Unrestricted opiate administration for pain and suffering at the end of life: knowledge and attitudes as barriers to care.

Iris Cohen Fineberg1, Neil S Wenger, Katherine Brown-Saltzman.   

Abstract

BACKGROUND: Pain and symptom management is critical for quality end-of-life care in the hospital. Although guidelines support the use of unrestricted opiate administration to treat refractory pain and suffering in the dying patient, many patients die suffering with symptoms that could have been addressed.
METHODS: A multidisciplinary convenience sample of 381 hospital-based health care providers completed a survey evaluating their understanding of the principles of treating refractory pain and suffering at the end of life in the hospital, knowledge of the institution's policy about how to implement such care, and attitudes about and comfort with such treatment.
RESULTS: Respondents recognized pain and symptom management as a goal of unrestricted opiate use at the end of life, but 12% identified comfort for families or treatment of nonphysical suffering as the principal goal of this modality. Two thirds of respondents felt that unrestricted opiates were used too rarely and 45% felt they were used too late. However, 16% felt uncomfortable administering unrestricted opiates and 21% of physicians and nurses who had used restricted opiates reported having felt pressured to increase dosing of opiates. Knowledge deficits concerning appropriate candidates for unrestricted opiates and the protocol for appropriate implementation were common.
CONCLUSIONS: Knowledge deficits and attitudinal concerns may hamper the administration of unrestricted opiates for refractory pain and suffering at the end of life in the hospital. Clinician education and clarification of the appropriate use of this modality when there are differences in clinician and family perception of discomfort are needed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16910802     DOI: 10.1089/jpm.2006.9.873

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  8 in total

1.  Can the Communion of Saints Help the Search for Justice in Dying well (Enough), "In Abraham's Arms, Where Lazarus is Poor no Longer"?

Authors:  William Joseph Buckley
Journal:  Linacre Q       Date:  2013-11-01

2.  Missed opportunities: use of an end-of-life symptom management order protocol among inpatients dying expected deaths.

Authors:  Anne M Walling; Susan L Ettner; Tod Barry; Myrtle C Yamamoto; Neil S Wenger
Journal:  J Palliat Med       Date:  2011-03-09       Impact factor: 2.947

3.  Characteristics of Belgian "life-ending acts without explicit patient request": a large-scale death certificate survey revisited.

Authors:  Kenneth Chambaere; Jan L Bernheim; James Downar; Luc Deliens
Journal:  CMAJ Open       Date:  2014-10-01

Review 4.  Pain and symptom management in palliative care and at end of life.

Authors:  Diana J Wilkie; Miriam O Ezenwa
Journal:  Nurs Outlook       Date:  2012-09-14       Impact factor: 3.250

5.  Assessment of implementation of an order protocol for end-of-life symptom management.

Authors:  Anne M Walling; Katherine Brown-Saltzman; Tod Barry; Rita Jue Quan; Neil S Wenger
Journal:  J Palliat Med       Date:  2008-07       Impact factor: 2.947

6.  Pain management in the elderly at the end of life.

Authors:  Roberta Rigo Dalacorte; Julio Cesar Rigo; Amauri Dalacorte
Journal:  N Am J Med Sci       Date:  2011-08

7.  A comparison of drugs and procedures of care in the Italian hospice and hospital settings: the final three days of life for cancer patients.

Authors:  Emily West; Massimo Costantini; H Roeline Pasman; Bregje Onwuteaka-Philipsen
Journal:  BMC Health Serv Res       Date:  2014-10-25       Impact factor: 2.655

8.  Differences in Characteristics, Hospital Care, and Outcomes between Acute Critically Ill Emergency Department Patients Receiving Palliative Care and Usual Care.

Authors:  Julia Chia-Yu Chang; Che Yang; Li-Ling Lai; Hsien-Hao Huang; Shih-Hung Tsai; Teh-Fu Hsu; David Hung-Tsang Yen
Journal:  Int J Environ Res Public Health       Date:  2021-11-28       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.